News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
828,615 Results
Type
Article (85498)
Company Profile (743)
Press Release (742374)
Section
Business (232195)
Career Advice (4099)
Deals (39638)
Drug Delivery (112)
Drug Development (90613)
Employer Resources (194)
FDA (17971)
Job Trends (17262)
News (395473)
Policy (39612)
Tag
Academia (2975)
Alliances (56404)
Alzheimer's disease (1310)
Approvals (17867)
Artificial intelligence (134)
Bankruptcy (394)
Best Places to Work (12432)
Biotechnology (506)
Breast cancer (109)
Cancer (943)
Career advice (3509)
Cell therapy (220)
Clinical research (71125)
Collaboration (340)
Compensation (161)
COVID-19 (2791)
Data (832)
Diabetes (140)
Diagnostics (6622)
Drug pricing (100)
Earnings (93916)
Employer resources (166)
Events (125952)
Executive appointments (250)
FDA (18412)
Funding (296)
Gene therapy (168)
GLP-1 (668)
Government (5037)
Healthcare (20693)
Infectious disease (2870)
Inflammatory bowel disease (113)
Interviews (806)
IPO (17553)
Job creations (5177)
Job search strategy (2853)
Layoffs (482)
Legal (10036)
Lung cancer (167)
Manufacturing (170)
Medical device (14372)
Medtech (14377)
Mergers & acquisitions (22053)
Metabolic disorders (407)
Neuroscience (1570)
NextGen Class of 2024 (7652)
Non-profit (5061)
Northern California (1176)
Obesity (241)
Opinion (240)
Patents (102)
People (63995)
Pharmaceutical (146)
Phase I (21863)
Phase II (30871)
Phase III (23309)
Pipeline (199)
Podcasts (85)
Postmarket research (3539)
Preclinical (9883)
Radiopharmaceuticals (256)
Rare diseases (201)
Real estate (7370)
Regulatory (25853)
Research institute (2638)
Resumes & cover letters (647)
Southern California (1079)
Startups (4274)
United States (12280)
Vaccines (631)
Weight loss (202)
Date
Today (234)
Last 7 days (854)
Last 30 days (3174)
Last 365 days (38919)
2024 (32282)
2023 (42566)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37192)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (221)
Asia (49202)
Australia (8668)
California (2797)
Canada (1162)
China (215)
Colorado (123)
Connecticut (130)
Europe (112647)
Florida (384)
Georgia (105)
Illinois (378)
Indiana (195)
Kansas (102)
Maryland (552)
Massachusetts (2345)
Michigan (160)
Minnesota (268)
New Jersey (840)
New York (839)
North Carolina (787)
Northern California (1176)
Ohio (131)
Pennsylvania (752)
South America (1647)
Southern California (1079)
Texas (404)
Washington State (347)
There are 828,615 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoff Tracker
Spero, ICON, Marinus and More Cut Staff
Follow along as
BioSpace
keeps you up-to-date on the latest pharma and biotech layoffs.
October 30, 2024
·
172 min read
·
BioSpace Editorial Staff
Layoffs
Spero Therapeutics to Lay Off 39% of Employees
Following disappointing results for an antibiotic candidate whose development program is now being suspended, Spero Therapeutics is looking to extend its cash runway while it focuses on other assets in its pipeline.
October 30, 2024
·
1 min read
·
Angela Gabriel
Earnings
Biogen Tops Wall Street Expectations for Leqembi, Inks Molecular Glue Deal
Biogen touted strong Q3 sales of its Alzheimer’s drug Leqembi a day after announcing a deal worth up to $1.45 billion with Neomorph to discover and develop molecular glue degraders.
October 30, 2024
·
2 min read
·
Heather McKenzie
Press Releases
Kapoose Creek Bio Acquires Exclusive License to Adapsyn Bioscience’s World-Leading AI Technology for Drug Development
October 30, 2024
·
3 min read
Press Releases
Avidity Biosciences Pursues Potential Accelerated Approval Path with Initiation of Biomarker Cohort in FORTITUDE™ Trial for Delpacibart Braxlosiran (del-brax/AOC 1020) in People Living with Facioscapulohumeral Muscular Dystrophy
October 30, 2024
·
11 min read
Press Releases
IMUNON to Present Phase 2 Data of IMNN-001 in Treatment of Newly Diagnosed Ovarian Cancer at SITC 39th Annual Meeting
October 30, 2024
·
5 min read
Press Releases
Replimune to Present at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
October 30, 2024
·
4 min read
Press Releases
Xilio Therapeutics to Present Initial Phase 1C Dose Escalation Data for XTX101 (Vilastobart) in Combination with Atezolizumab in a Late-Breaker Poster at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
October 30, 2024
·
5 min read
Press Releases
Femasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeed
October 30, 2024
·
7 min read
Press Releases
Dogwood Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
October 30, 2024
·
3 min read
1 of 82,862
Next
